Royalty Pharma plc Income Statement

1Y3Y5Y7Y10YAll
Download Data
Income Statement Dec2018 Dec2019 Dec2020 Dec2021 Dec2022 Dec2023 Dec2024
Revenue & cost
Revenue 1794.89M1814.25M2122.35M2289.46M2237.22M2354.55M2263.58M
Cost of Revenue 65.05M
Gross Profit 1794.89M1814.25M2057.30M2289.46M2237.22M2354.55M2263.58M
Operating items
Amortization - Intangibles 33.27M23.92M23.06M23.00M5.67M
Research & Development 392.61M83.04M26.30M200.10M177.11M52.00M2.00M
Selling, General & Administrative 61.91M103.44M181.72M182.83M227.30M249.75M236.67M
Other Operating Expenses -24.07M-995.40M318.94M475.82M1525.74M560.66M732.46M
Operating Expenses 430.45M-808.92M526.95M858.75M1930.15M862.40M971.13M
Operating Income 1364.45M2623.18M1595.40M1430.71M307.06M1492.15M1292.44M
EBIT 1364.45M2623.18M1595.40M1430.71M307.06M1492.15M1292.44M
Non-operating items
Non Operating Investment Income 11.92M-39.14M-42.08M-21.53M96.61M-2.29M-6.00M
Interest & Investment Income 24.44M22.33M28.38M53.53M78.33M72.29M47.34M
Other Non Operating Income -1.52M0.39M-32.82M-5.68M-14.76M-21.74M-1.53M
Non Operating Income 153.41M-161.76M106.56M-189.51M-77.00M207.94M38.37M
Net income details
EBT 1517.86M2461.42M1701.95M1241.20M230.06M1700.09M1330.81M
Profit After Tax 1517.86M2461.42M1701.95M1241.20M230.06M1700.09M1330.81M
Equity Income -13.94M155.75M247.07M-48.07M-33.44M87.14M39.55M
Income from Non-Controlling Interests 140.13M112.88M726.91M621.47M187.23M565.25M471.83M
Income from Continuing Operations 1517.86M2461.42M1701.95M1241.20M230.06M1700.09M1330.81M
Consolidated Net Income 1517.86M2461.42M1701.95M1241.20M230.06M1700.09M1330.81M
Income towards Parent Company 1517.86M2461.42M1701.95M1241.20M230.06M1700.09M1330.81M
Net Income towards Common Stockholders 1517.86M2461.42M1701.95M1241.20M230.06M1700.09M1330.81M
Additional items
EPS (Basic) 0.00M0.00M0.00M0.00M0.00M0.00M
EPS (Weighted Average and Diluted) 0.00M0.00M0.00M0.00M0.00M
Shares Outstanding (Weighted Average) 595.38M607.11M607.17M607.22M597.43M589.18M
Shares Outstanding (Diluted Average) 375.45M414.80M437.97M602.90M594.11M
EBITDA 983.23M2360.88M1041.67M1430.71M307.06M1492.15M1292.44M